BGI GENOMICS
BGI Genomics, headquartered in Shenzhen, China, is the world's leading integrated solutions provider of precision medicine. The company has pioneered thalassemia genetic testing services based on next-generation sequencing (NGS) technology since 2013. In July 2017, as a subsidiary of BGI Group, BGI Genomics was officially listed on the Shenzhen Stock Exchange.
Disclaimer : All logos and trademarks on this website are the property of their respective owners. The information on this website is not a medical or investment related advice. The information about the company might not reflect the most current or accurate information. Please refer to the company's respective website for the most accurate information.